Tempo Scan records 20.2% hike in 1Q net income

JAKARTA: An Indonesia-based pharmaceutical company, PT Tempo Scan Pacific Tbk, booked 20.2% net income rise to IDR192 billion in the first quarter on increasing revenue.In a press statement published today, the company said the sales figure grew by 8% to IDR1.31 trillion in the first three months ending March despite generally slower market growth for pharmaceutical as well as consumer products in the beginning of 2011.Tempo Scans operating income increased 17.1% in the first quarter 2011 to IDR207.1 billion, compared to the same period last year. Its operating income margin rose to 15.8% compared to 14.6% in the first quarter last year.Furthermore, the companys net cash position as of March 31, 2011 was IDR1.34 trillion.The TSPC-coded stock declined 1.12% or IDR25 to IDR2,200 at the Indonesia Stock Exchange as of 2.41 p.m. It shares were traded with a P/E ratio of 20.10. Its competitor was traded in different P/E ratio, for instance PT Kalbe Farma Tbk with P/E ratio of 23.96, PT Merck Tbk with 18.14, PT Darya Varia Laboratoria Tbk with 11.12, PT Kimia Farma Tbk with 7.34, and PT Indofarma Tbk with 21.71. (NOM)